Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.36 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.36 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.36 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.36 |
| ▸ | PYGB | P11216 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.33 |
| ▸ | STAT3 | P40763 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18805239 | 1.00 | CA2 (0.39) | CA2LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL15468823 | 1.00 | CA2 (0.39) | CA2LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL9973539 | 0.94 | CA2 (0.45) | CA2LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL9973538 | 0.90 | CA2 (0.43) | CA2LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL13820240 | 0.87 | PYGB (0.33) | CA2PYGBSTAT3 | |
| SCHEMBL14883472 | 0.86 | PYGB (0.40) | CA2LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL25834664 | 0.86 | CA2 (0.39) | CA2LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL16882336 | 0.86 | CA2 (0.56) | CA2GAASTAT3 | |
| SCHEMBL23685882 | 0.85 | CA2 (0.50) | CA2LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL13920841 | 0.85 | CA2 (0.50) | CA2LGALS1LGALS3LGALS9LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120156153-A1 | Naturally Derived, Polymeric Hair Fixative Systems With Pullulan, And Mascara Compositions Comprising The Same | FOGG STANLEY R (US) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120156153-A1 | Naturally Derived, Polymeric Hair Fixative Systems With Pullulan, And Mascara Compositions Comprising The Same | CUTA, HIRA, NACA | CA2 2393/4885LGALS1 2751/4885LGALS3 779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.